|
Volumn 3, Issue 4, 2007, Pages 573-581
|
CNS pharmacokinetics of antifungal agents
|
Author keywords
Antifungal; Central nervous system; Cerebrospinal fluid; Pharmacokinetics
|
Indexed keywords
AMPHOTERICIN B;
AMPHOTERICIN B LIPID COMPLEX;
ANIDULAFUNGIN;
ANTIFUNGAL AGENT;
CASPOFUNGIN;
ECHINOCANDIN;
FLUCONAZOLE;
FLUCYTOSINE;
ITRACONAZOLE;
MICAFUNGIN;
POSACONAZOLE;
TRIAZOLE;
VORICONAZOLE;
TRIAZOLE DERIVATIVE;
AREA UNDER THE CURVE;
ASPERGILLOSIS;
BLASTOMYCOSIS;
BLOOD BRAIN BARRIER;
CENTRAL NERVOUS SYSTEM INFECTION;
CEREBROSPINAL FLUID ANALYSIS;
CLINICAL TRIAL;
COCCIDIOIDOMYCOSIS;
CRYPTOCOCCAL MENINGITIS;
DRUG ACCUMULATION;
DRUG BRAIN LEVEL;
DRUG EFFICACY;
DRUG PENETRATION;
DRUG PROTEIN BINDING;
HISTOPLASMOSIS;
HUMAN;
INVASIVE CANDIDIASIS;
LIPOPHILICITY;
MINIMUM INHIBITORY CONCENTRATION;
MUCORMYCOSIS;
MYCOSIS;
NONHUMAN;
PARENCHYMA;
PHYSICAL CHEMISTRY;
REVIEW;
ANIMAL;
CENTRAL NERVOUS SYSTEM;
CEREBROSPINAL FLUID;
METABOLISM;
FUNGI;
AMPHOTERICIN B;
ANIMALS;
ANTIBIOTICS, ANTIFUNGAL;
ANTIFUNGAL AGENTS;
CENTRAL NERVOUS SYSTEM;
FLUCYTOSINE;
HUMANS;
TRIAZOLES;
|
EID: 85047685056
PISSN: 17425255
EISSN: None
Source Type: Journal
DOI: 10.1517/17425255.3.4.573 Document Type: Review |
Times cited : (101)
|
References (72)
|